Characterization of the Nucleoside Triphosphate Phosphohydrolase and Helicase Activities of the Reovirus lambda 1 Protein*

(Received for publication, January 31, 1997, and in revised form, May 12, 1997)

Martin Bisaillon , Josée Bergeron Dagger and Guy Lemay §

From the Département de Microbiologie et Immunologie, Université de Montréal, Montréal, Québec H3C 3J7, Canada

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Previous studies have shown that the reovirus lambda 1 core protein harbors a putative nucleotide-binding motif and exhibits an affinity for nucleic acids. In addition, a nucleoside triphosphate phosphohydrolase activity present in reovirus cores has been recently assigned to lambda 1 using gene reassortment analysis. In this study, it was demonstrated that the recombinant lambda 1 protein, expressed in the yeast Pichia pastoris, is able to hydrolyze nucleoside 5'-triphosphates or deoxynucleoside 5'-triphosphates. This activity was absolutely dependent on the presence of a divalent cation, Mg2+ or Mn2+. The protein can also unwind double-stranded nucleic acid molecules in the presence of a nucleoside 5'-triphosphate or deoxynucleoside 5'-triphosphate. These results provide the first biochemical evidence that the reovirus lambda 1 protein is a nucleoside triphosphate phosphohydrolase/helicase and strongly support the idea that lambda 1 participates in transcription of the viral genome.


INTRODUCTION

Mammalian reoviruses are members of the Reoviridae family, and since their genome is made up of 10 segments of double-stranded RNA (dsRNA)1 and replicates in the cytoplasm, they must encode their own transcriptional and replicative enzymes (1). During reovirus infection, the viral genome remains in the inner capsid (core) of the virus, composed of two major (lambda 1 and sigma 2) and two minor (lambda 3 and µ2) proteins. Gene reassortment experiments have resulted in the assignment of transcriptase activity to lambda 3 (2). Although functions of other core proteins have not been firmly established, it is suspected that additional enzymatic functions are needed to achieve transcription and replication of the viral genome. For example, it has been postulated, by analogy with other viruses, that a helicase function could be present in the viral core (1).

Nucleic acid helicases unwind double-stranded DNA and/or RNA, a process energetically coupled to the hydrolysis of nucleoside 5'-triphosphates (NTPs) or deoxynucleoside 5'-triphosphates (dNTPs) (3, 4). Helicases play a key role in nucleic acid replication, transcription, splicing, translocation, recombination, and repair (5-8). Helicases of prokaryotic, eukaryotic, and viral origins have been isolated and classified into defined superfamilies (9-14). These proteins are characterized by seven conserved motifs designated I, Ia, and II-VI (15). Motifs I and II are very well conserved and correspond to the A and B consensus sequences of a nucleotide-binding domain (16). Superfamily II includes an expanding group of DNA and RNA helicases that harbor a DEA(D/H) sequence in motif II (17). The sequences present in motifs III-V are less strictly conserved, and their roles are not clearly defined, whereas motif VI is supposed to be involved in nucleic acid binding given its high content of positively charged amino acids (13).

The lambda 1 protein, a major component of the reovirus core, exhibits an affinity for dsRNA and dsDNA in filter binding assays and can also bind single-stranded RNA in gel retardation assays (18).2 Furthermore, analysis of gene reassortment has recently resulted in the assignment of NTPase activity present in reovirus cores to the L3 gene encoding lambda 1 (19). In this study, we present a biochemical characterization of the enzymatic activities exhibited by the lambda 1 protein encoded by the cloned L3 gene. The protein was expressed in the yeast Pichia pastoris and recovered by chromatography using the affinity of the protein for zinc, which is conferred by its zinc-finger motif. This protein was able to hydrolyze all NTPs and dNTPs with release of inorganic phosphate; however, different NTPs and dNTPs are utilized with various efficiencies. The protein can also unwind double-stranded nucleic acid molecules; this reaction requires the presence of a NTP or dNTP at a concentration consistent with a functional coupling between hydrolysis of nucleotide and helicase activity. These findings strongly support the idea that lambda 1 participates as a helicase during transcription of the viral genome.


EXPERIMENTAL PROCEDURES

Expression and Enrichment of lambda 1

The methylotrophic yeast P. pastoris strain GS115 (his4) was used for the expression of lambda 1. All manipulations were performed according to the manufacturer's instructions (Invitrogen). The 5'-end of the cloned L3 gene encoding lambda 1 was first reconstructed by polymerase chain reaction to remove homopolymers introduced in the original cloning procedure (20). The lambda 1 expression plasmid pHIL-L3 was then constructed by inserting the complete L3 gene of reovirus serotype 3 at the unique EcoRI site of the pHIL-D2 expression vector. The pHIL-D2 expression vector contains a HIS4 gene, and its unique EcoRI site is flanked by the 5'- and 3'-regulatory sequences of the methanol-inducible alcohol oxidase gene (AOX1) of P. pastoris. Yeast cells were transformed with linear (NotI-digested) DNA of pHIL-D2 or pHIL-L3 and selected on histidine-deficient medium. Transformants were identified, liquid cultures were prepared, and protein expression was induced by the addition of 0.5% methanol for 20 h at 30 °C. The yeast cells were recovered by centrifugation and disrupted with glass beads, and the lysates (1 ml) were submitted to affinity chromatography on zinc chelate affinity adsorbent columns (Boehringer Mannheim). The columns were washed extensively (100 ml) with wash buffer (50 mM Tris-HCl, pH 8.0, and 150 mM NaCl), and the bound proteins were eluted sequentially with 1 ml of elution buffers, each made of 0.1 M sodium phosphate and 0.8 M NaCl and adjusted at pH 7.5, 7.0, 6.5, 6.0, or 5.5 (21). Protein dosage was performed using the Bradford protein assay (Bio-Rad).

Western Blot Analysis

Proteins were submitted to electrophoresis on SDS-10% polyacrylamide gels. Following electrophoresis, the proteins were transferred to a nitrocellulose filter and probed with a 1:1000 dilution of monospecific anti-lambda 1 antibody (a generous gift of Dr. Michael R. Roner, Florida Atlantic University). The antigen-antibody complexes were detected using a goat anti-rabbit IgG conjugated to horseradish peroxidase and the Amersham enhanced chemiluminescence Western blotting kit.

NTPase and dNTPase Assays

Standard reactions (22) were performed in a buffer containing 30 mM Hepes-KOH, 2 mM MgCl2, and 0.2 pmol of [gamma -32P]ATP (4500 Ci/mmol; ICN). Approximately 18 fmol (2.5 ng) of lambda 1 protein were used in each 15-µl reaction when an enriched lambda 1 fraction recovered from zinc affinity chromatography was used. The reactions were incubated at various temperatures and stopped by the addition of 0.1 M EDTA at the times indicated. The ATPase activity was detected by the release of 32Pi from [gamma -32P]ATP. Reaction products (2 µl) were applied onto plastic-backed polyethyleneimine cellulose sheets (Aldrich) and separated by ascending chromatography in 0.375 M potassium phosphate buffer, pH 3.5. The sheets were then air-dried and subjected to autoradiography.

The Michaelis-Menten constant (Km) was determined by the isotopic dilution method with unlabeled ATP. A similar experiment was performed with [gamma -32P]GTP (4500 Ci/mmol; ICN) and unlabeled GTP. The determination of Km for dATP and dCTP was performed with 0.2 pmol of [alpha -32P]dATP (3000 Ci/mmol; ICN) or [alpha -32P]dCTP (3000 Ci/mmol; ICN) using isotopic dilution with unlabeled dATP and dCTP, respectively. In these two cases, deoxynucleoside triphosphate substrates were separated from deoxynucleoside diphosphate reaction products by polyethyleneimine cellulose chromatography in 0.8 M acetic acid and 0.9 M LiCl buffer.

The spots corresponding to the radiolabeled substrates or reaction products were identified following autoradiography; the corresponding regions were then excised from the polyethyleneimine cellulose sheets; and the radioactivity was measured by Cerenkov counting. For calculations, background values were first subtracted from product values by quantitation of radioactivity at the same level on chromatograms of control unincubated substrate. Thereafter, the ratio of generated products to total material was calculated by quantitation of both reaction products and residual substrate in each lane.

Synthesis of Helicase Substrates

The substrate for the DNA helicase assay was prepared by annealing the 17-base pair universal primer (5'-GTAAAACGACGGCCAGT-3') to single-stranded M13 DNA. Chain elongation was then performed with Sequenase (U. S. Biochemical Corp.) for 30 min at 37 °C in the presence of dGTP, dTTP, and [alpha -32P]dATP. The resulting substrate contained an extended radiolabeled oligomer of 22 nucleotides hybridized to M13 DNA and was purified by gel filtration (Sephadex G-25) to remove most of the unincorporated nucleotides.

The substrate for RNA helicase activity was prepared as a partial RNA duplex using pBluescript II SK+ (Stratagene), which contains the T3 and T7 polymerase promoters. The first strand (59 nucleotides) was prepared by in vitro transcription with T3 RNA polymerase (Pharmacia Biotech Inc.) of the SmaI-digested plasmid. The labeled strand (89 nucleotides) was synthesized from the XbaI-digested plasmid in the presence of [alpha -32P]UTP with T7 RNA polymerase (Pharmacia). The original DNA templates were removed by DNase treatment (RQ1 DNase, RNase-free), extracted in phenol/chloroform, and precipitated with ethanol. The two RNA species were dissolved in a buffer containing 10 mM Tris-HCl, pH 7.5, and 200 mM NaCl. The RNAs were then annealed by heating to 90 °C for 15 min and cooled to room temperature to produce a tailed RNA molecule with a 17-base pair duplex region.

Helicase Assays

In the standard assay (23), the DNA and RNA substrates (0.3 pmol) were used in a total volume of 15 µl containing 25 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 20 mM NaCl, 1 mM dithiothreitol, and 5 mM ATP. Approximately 18 fmol (2.5 ng) of lambda 1 protein were used in each 15-µl reaction when the enriched lambda 1 fraction recovered from zinc affinity chromatography was used; incubation was for 30 min at 37 °C. Components were added or removed in some reactions, as described below. The reactions were stopped by adding 0.5% SDS, 50 mM EDTA, and 40% glycerol. The reaction products were analyzed by electrophoresis on 15% (DNA) or 10% (RNA) nondenaturing Tris borate/EDTA-polyacrylamide gels. The gels were dried under vacuum and exposed for autoradiography.


RESULTS

Expression and ATPase Activity of Recombinant lambda 1

Sequence comparisons revealed that lambda 1 possesses two nucleotide-binding motifs normally present in NTPase (Fig. 1): a PRKTKGKS sequence (A site) in the N-terminal region and a DEAD motif (B site). Furthermore, lambda 1 harbors the characteristic motifs found in members of the RNA/DNA helicase superfamily II, with slight variations occurring in certain motifs. To study these putative enzymatic activities, the lambda 1 protein encoded by the cloned L3 gene was expressed using the P. pastoris yeast expression system as described under "Experimental Procedures." Enrichment of the protein and removal of endogenous yeast ATPases were then achieved by affinity chromatography, taking advantage of the presence of a putative zinc-binding finger motif on lambda 1.


Fig. 1. Consensus sequence motifs in reovirus lambda 1 protein. Consensus sequence motifs of RNA/DNA helicases are illustrated. x indicates any amino acid. The A and B consensus sequences of the nucleotide-binding domain are also indicated. The homologous regions in lambda 1 are presented and aligned with helicase motifs. Numbers refer to amino acid positions starting from the amino-terminal end of the lambda 1 protein.
[View Larger Version of this Image (22K GIF file)]

The expression level of lambda 1 was too low for detection by either Coomassie Blue or silver staining in the purified fractions (data not shown). However, immunoblotting analysis, using a monospecific anti-lambda 1 antibody, did reveal the enrichment of an immunoreactive protein in the eluted fractions; this protein comigrated with the authentic lambda 1 protein found in purified reovirions (Fig. 2A). The amount of lambda 1 protein in these fractions was estimated to be ~0.5 ng/µl by comparisons with the signal obtained by immunoblotting using serial dilutions of purified reovirus as a standard. Protein dosage also revealed that enrichment of the protein was ~10-fold compared with the crude lysate (Table I).


Fig. 2. Expression of lambda 1 and purification of ATPase activity from yeast cells. A, protein samples were analyzed by electrophoresis on SDS-polyacrylamide gels followed by Western blotting with anti-lambda 1 antibody. Samples consisted of 75 and 30 µg of reovirus (lanes 1 and 2, respectively), 2.2 mg of crude lysate from cells harboring the control vector pHIL-D2 (lane 3), 2.2 mg of crude lysate from yeast cells harboring the lambda 1 expression vector pHIL-L3 (lane 4), 225 µg of eluate fraction from yeast cells harboring pHIL-D2 (lane 5), and 225 µg of eluate fraction from yeast cells harboring pHIL-L3 (lane 6). B and C, lysates obtained from yeast cells harboring the control vector pHIL-D2 (B) or the lambda 1 expression vector pHIL-L3 (C) were submitted to affinity chromatography on zinc chelate adsorbent columns. The columns were washed, and proteins were eluted at various pH values. Aliquots were recovered from original lysates (supernatant (SN)), flow-through fraction (FT), wash fractions (second (W2), fourth (W4), sixth (W6), and eighth (W8)) and eluates at various pH values. Each aliquot was analyzed for ATPase activity by thin-layer chromatography as described under "Experimental Procedures." An aliquot of the original substrate was analyzed in parallel as a control (-). The positions of the ATP substrate and inorganic phosphate product (Pi) are indicated.
[View Larger Version of this Image (37K GIF file)]

Table I. Summary of lambda 1 protein enrichment

Aliquots from crude lysates or eluate fractions from affinity chromatography steps were assayed for ATPase activity. Specific activity was calculated relative to the total protein amounts, measured by the Bradford protein dosage assay (Bio-Rad). The amount of lambda 1 protein was estimated by comparisons with the signal obtained by immunoblotting using serial dilutions of purified reovirus as a standard. The volumes listed represent total volumes of each fraction.

Chromatography step Volume Total protein  lambda 1 protein ATPasea Specific activity

ml mg ng units units/mg
pHIL-D2 crude lysate 10 250 0 2540 10.2
pHIL-D2 eluate fractionb 1 2.5 0 0 0
pHIL-L3 crude lysate 10 250 8000 3800 15.2
pHIL-L3 eluate fractionb 1 2.5 500 340 136

a One unit is defined as the amount of enzyme that will generate 1 fmol of inorganic phosphate/min.
b This is the eluate fraction obtained at pH 7.5.

The lambda 1 protein expressed in P. pastoris was first tested for its ability to hydrolyze ATP by monitoring the amount of free radioactive inorganic phosphate liberated upon incubation of the protein fractions with [gamma -32P]ATP. As shown in Fig. 2 (B and C), ATPase activity endogenous to P. pastoris was found in the flow-through and first wash fractions of the zinc column, but dropped to undetectable levels in later wash fractions. Following elution at lower pH, ATPase activity was recovered from cultures harboring the lambda 1 expression vector (Fig. 2C), whereas equivalent fractions from control cultures harboring vector with no insert were devoid of ATPase activity (Fig. 2B). The same results were obtained from five independent negative cultures and two separate cultures expressing recombinant lambda 1 (data not shown). A summary of the lambda 1 enrichment procedure is presented in Table I; the eluate fraction obtained at pH 7.5 was used in the rest of this work.

In an effort to further rule out any possible contamination with a copurifying yeast enzyme, thermoresistance of the NTPase activity was examined (Fig. 3). The approach used takes advantage of the fact that reovirus core enzymes are active at high temperature, whereas P. pastoris has an optimal growth temperature of 30 °C, and its enzymes are thus expected to be thermosensitive. Cell extracts from yeast cells harboring the control vector (pHIL-D2) or lambda 1 expression vector (pHIL-L3) were thus examined for ATPase activity prior to or following heating at 42 °C for an extended period (5 h). This treatment essentially abolished the yeast endogenous ATPase activity (Fig. 3A), whereas part of the activity was retained in lysates from lambda 1-expressing yeast cells (Fig. 3B); the ATPase activity present in lambda 1-enriched fractions from zinc chelate affinity chromatography was completely resistant to thermal inactivation (Fig. 3D), whereas no activity was found in eluate fractions from yeast cells harboring the control vector pHIL-D2 (Fig. 3C).


Fig. 3. Thermoresistance of lambda 1-associated NTPase activity. Crude lysates were obtained from yeast cells harboring the control vector pHIL-D2 or from yeast cells harboring the lambda 1 expression vector pHIL-L3. Eluate fractions obtained at pH 7.5 from the zinc affinity chromatography procedure were also prepared from the same two lysates. These protein samples were heated at 42 °C for 5 h; an aliquot was kept on ice for the same time. Assays for ATPase activity were then performed at 37 °C using the standard procedure, and hydrolysis was measured at different times. A, crude lysate from control cells harboring pHIL-D2; B, crude lysate from yeast cells harboring pHIL-L3; C, eluate fraction from yeast cells harboring pHIL-D2; D, eluate fraction from yeast cells harboring pHIL-L3. square , control protein samples kept for 5 h on ice prior to use in the reaction; black-square, protein samples heated at 42 °C for 5 h prior to the reaction.
[View Larger Version of this Image (22K GIF file)]

Characterization of lambda 1 NTPase/dNTPase Activity

The enzymatic activity of recombinant lambda 1 found in elution fractions was then further investigated. This activity was absolutely dependent on the presence of the divalent cation Mg2+ or Mn2+, whereas the Ca2+, Cu2+, and Zn2+ cations were not effective cofactors (data not shown). The ATPase activity increased sharply with MgCl2 concentration, reached a maximum at 2.5 mM, and was constant up to 10 mM (Fig. 4A). Similar results were obtained when Mn2+ was substituted for Mg2+ (data not shown).


Fig. 4. Characterization of lambda 1-associated ATPase activity. The effect of MgCl2 concentration (A), temperature (B), and ATP concentration (C) on the lambda 1-associated ATPase activity was examined. Reactions were performed under standard conditions as described under "Experimental Procedures," except that the MgCl2 (A) and ATP (C) concentrations were varied. Incubations were all performed at 37 °C except in B, where the enzyme was incubated at various temperatures for up to 1 h.
[View Larger Version of this Image (17K GIF file)]

To gain additional insight into the lambda 1-associated ATPase activity, the effect of temperature on the reaction was examined (Fig. 4B). The temperature optimum of the reaction, as judged by the maximum rate of ATP hydrolysis, was 42-50 °C; however, the activity was rapidly lost upon incubation at 50 °C. A 1-h incubation at 42, 37, and 30 °C resulted in similar rates of ATP hydrolysis, whereas the enzyme was less active at 25 °C.

The kinetics parameters of the reaction were determined at 37 °C and 10 min, at which time the reaction is still proceeding at its initial rate. The ATPase reaction velocity reached a plateau at ~7 µM ATP and exhibited a Km of 1 µM as determined by a double-reciprocal plot (Fig. 4C). Identical results were obtained in three separate experiments.

To determine the substrate specificity of the lambda 1 protein, the hydrolysis of other ribonucleotides and deoxyribonucleotides was also tested. The protein exhibited a strong preference for adenosine nucleotides (ATP and dATP), which were hydrolyzed very efficiently. The enzyme displayed some activity on other NTPs and dNTPs tested, although the efficiency was different from one substrate to the other; the order of preference was dATP > ATP > GTP > dCTP according to the kcat values obtained with these substrates (Table II).

Table II. Kinetic analysis of alternative nucleoside triphosphate phosphohydrolysis


Substrate Km a kcat b Vmax a

µM min-1 mol/min
ATP 1.0 12.6 2.3  × 10-13
GTP 2.0 5.3 9.7  × 10-14
dATP 6.6 93.4 1.7  × 10-12
dCTP 7.1 1.3 2.3  × 10-14

a Values for Km and Vmax were determined from Lineweaver-Burk plots of hydrolysis activity. Reactions were conducted with NTP and dNTP concentrations varying between 0.0125 and 15 µM.
b kcat values were calculated from the purified lambda 1 protein concentration estimated by immunoblotting using serial dilutions of purified reovirus as a standard.

RNA and DNA Helicase Activities of lambda 1

The ability of the lambda 1 protein to unwind double-stranded nucleic acids was then investigated. The RNA helicase reaction catalyzed by the reovirus lambda 1 protein was demonstrated by strand displacement of a partial RNA duplex as described under "Experimental Procedures." The lambda 1-associated RNA helicase activity required the presence of ATP, which could be substituted by either one of the NTPs and dNTPs (Fig. 5A) (data not shown). The unwinding activity was also dependent on the presence of a divalent cation (Mg2+ or Mn2+), as was the NTPase/dNTPase activity.


Fig. 5. RNA and DNA helicase activities of lambda 1. Standard RNA (A) and DNA (B) helicase assays were performed in the absence of NTPs and dNTPs (-NTPs) or using ATP (5 mM) or dATP (5 mM) as an energy source. All reactions were run on polyacrylamide gels as described under "Experimental Procedures." A reaction without Mg2+ in the presence of ATP was also analyzed (-Mg2+). Thermoresistance of helicase activity was then investigated (C). The DNA helicase assay was performed prior to (-) or after (+) heat treatment of the protein samples for 5 h at 42 °C. Reactions were performed in the presence of crude lysate from control yeast cells harboring the pHIL-D2 vector (Crude D2) and eluate fractions from cells harboring pHIL-D2 (Eluate D2) or pHIL-L3 (Eluate lambda 1). Control substrates incubated in the absence of protein or heat-denatured to reveal the expected reaction products were run in parallel. The positions of substrates and reaction products are indicated.
[View Larger Version of this Image (38K GIF file)]

The helicase activity on a DNA substrate was also tested by the ability of the protein to displace (unwind) a short oligonucleotide annealed to single-stranded M13 DNA. As shown in Fig. 5B, the lambda 1 protein is able to unwind the partial DNA duplex in the presence of either ATP or dATP. This lambda 1-associated DNA helicase activity could also be stimulated by all NTPs and dNTPs (data not shown) and had the same requirement for divalent cations as the RNA helicase activity.

Additional controls were also performed to ensure that the helicase activity could not be due to a copurifying yeast protein. Crude lysate from control yeast cells was examined for the presence of helicase activity and was found to be negative. Furthermore, the enriched eluate from the zinc affinity column was also negative in the control cells, whereas the activity found in purified lambda 1 eluate fractions was thermoresistant (Fig. 5C), as was the NTPase activity.


DISCUSSION

Our understanding of the roles of individual core proteins in reovirus replication is still incomplete, although genetic information has been accumulated during the past few years (24, 25). Investigation of the biochemical activity of the reovirus lambda 1 protein was inspired by sequence comparisons with other NTPase/helicase proteins. Although the lambda 1 protein does not show any significant similarities to other proteins, it possesses the characteristic motifs found in the DEAD subfamily of the RNA/DNA helicase superfamily II. All these motifs are located in the amino-terminal third of lambda 1; the affinity of the protein for nucleic acids was previously assigned to this region (18). Being one of the largest reovirus proteins, the lambda 1 protein could not be easily expressed in bacterial expression systems. The recently described P. pastoris yeast expression system was instead used as a convenient way to produce recombinant lambda 1. The expression levels obtained were low but sufficient for investigations of lambda 1 catalytic activities. The reason for this low expression level is unknown, but might reflect toxicity of NTPase activity when overexpressed, thus resulting in the selection of cell clones expressing lower levels of the protein. Expression levels using P. pastoris have been reported to vary widely among proteins (Invitrogen). Since a truncated form of lambda 1 encompassing the zinc-finger motif was previously expressed as a fusion protein in bacterial cells (18) and found to attach to zinc chelate columns,3 this procedure was thus adequate for lambda 1 recovery. The zinc affinity chromatography procedure allowed us to efficiently reduce endogenous NTPase and helicase activities below the detection level of our assays while enriching both immunodetectable lambda 1 and its associated NTPase activity by ~10-fold. Thermoresistance was an additional proof that the NTPase activity measured could not be due to a contaminating yeast protein; although it is expected that NTPase activity could be abundant in yeast cells, those endogenous activities were completely inactivated upon extensive heat treatment.

All four NTPs and dNTPs tested were hydrolyzed by lambda 1, and it is most likely that all NTPs and dNTPs can be hydrolyzed since either one of them can substitute for ATP in the helicase assay. The efficiency of utilization appears to vary among the different NTPs and dNTPs, with the highest rate of hydrolysis for dATP, followed by ATP and other NTPs. However, it should be mentioned that even though all Km values are in the micromolar range, they are lower for NTPs than for dNTPs. At a low concentration of substrates, as might be the case inside the viral core in vivo, ATP will thus likely be the preferred energy source.

A NTPase activity has been previously found in purified reovirus cores (19, 26, 27), and the activity has been recently assigned to lambda 1 using gene reassortment analysis (19). Interestingly, the core enzyme is capable of hydrolyzing either NTPs or dNTPs in the presence of Mg2+ or Mn2+ and also has an unusual temperature optimum of 51 °C (27, 28). The observation that dATP was more efficiently hydrolyzed relative to ATP at high substrate concentration was also made in previous studies (19, 27). The catalytic properties of the recombinant lambda 1 protein analyzed in this study are consistent with these previous findings and further support the idea that lambda 1 is the protein responsible for the NTPase activity observed in reovirus cores.

The recombinant lambda 1-associated NTPase/dNTPase had an apparent temperature optimum of 50 °C, but the activity declined rapidly at this high temperature, most likely due to thermal inactivation of the enzyme. Recent studies indicated that lambda 1 interacts with the lambda 3 (polymerase) and lambda 2 (guanylyltransferase) core proteins (29, 30); such interactions might account for the higher stability of NTPase activity found in purified viral cores compared with the isolated recombinant lambda 1 protein.

The Km values for ATP and GTP hydrolysis calculated from Lineweaver-Burk plots were 1 and 2 µM, respectively. These Km values are in the same range observed for the well studied SV40 large T antigen, which is also a DNA and RNA helicase (31). To date, only three other viral helicases have been shown to possess both DNA and RNA helicase activities; they are SV40 large T antigen, vaccinia virus protein 18R, and hepatitis C virus protein NS3 (32-34). One cellular eukaryotic protein, nuclear DNA helicase II, also possesses the ability to unwind dsDNA and dsRNA substrates (35). The reovirus lambda 1 protein shares with these four helicases the ability to hydrolyze all NTPs and dNTPs. However, SV40 large T antigen unwinds dsDNA when ATP is present, but unwinds dsRNA with UTP, CTP, or GTP as cofactor (32). The bound nucleotide seems to determine whether the T antigen acts as an RNA or DNA helicase. In contrast, the reovirus lambda 1 protein and hepatitis C virus protein NS3 can use the energy provided by the hydrolysis of any NTPs or dNTPs for both their RNA and DNA helicase activities (34).

Many viral helicases have high basal NTPase activity in the absence of added nucleic acids. This is the case of the potyvirus-flavivirus-pestivirus proteins that have been recently characterized (36-39). In this respect, they differ from most cellular proteins of the NTPase/helicase superfamilies. For example, cellular protein p68 and eukaryotic translation initiation factor 4A exhibit almost no detectable ATPase activity in the absence of RNA (40, 41). Our results demonstrated that the reovirus lambda 1 protein, like many viral NTPases, also exhibits NTPase and dNTPase activities in the absence of added nucleic acids. Although it cannot be completely excluded that nucleic acids can stimulate NTPase activity, the addition of various nucleic acids (single-stranded DNA, dsDNA, single-stranded RNA, and dsRNA) has failed to produce a significant change in kcat values for NTPase activity (data not shown).

The helicase activity of lambda 1 was not detected at an ATP concentration of 0.1 µM and was maximal at 10 µM (data not shown). This is consistent with the Km value of 1 µM for ATPase activity and with a probable functional coupling between the two reactions where NTP or dNTP hydrolysis generates the energy required for unwinding of nucleic acids.

The significance, if any, of the DNA helicase activity of the lambda 1 protein is currently not understood, but a previous report already demonstrated the lambda 1 affinity for dsRNA and dsDNA in filter binding assays (18). As previously mentioned, the NS3 protein from hepatitis C virus is another example of an RNA virus protein with an associated DNA helicase activity. Like the reovirus lambda 1 protein, the role of the DNA helicase activity in the multiplication cycle or pathogenesis of hepatitis C virus is not yet established (34).

In addition to earlier genetic evidence that assigned transcriptase activity to lambda 3, more recent biochemical evidence has confirmed that this protein possesses RNA polymerase activity (29). However, the protein appears to be unable by itself to transcribe its natural dsRNA substrate. This has led to the idea that additional proteins are involved in transcription. The lambda 1-associated RNA helicase activity reported in this study strongly suggests an involvement of this protein in the transcription of the double-stranded reovirus genome.

Although it is possible that normal transcription and replication of the viral genome require the formation of a well structured core or the participation of cellular protein(s), this report is the third case, with the previous examples of lambda 2 and lambda 3 (29, 42), where an actual enzymatic activity could be demonstrated on a solubilized reovirus protein. To our knowledge, this report of lambda 1 helicase activity is the first demonstration of such an activity in a mammalian dsRNA virus.

The reovirus core also contains enzymes that modify the 5'-end of newly synthesized mRNAs by adding a cap structure similar to the one present on cellular mRNAs (43, 44). An RNA triphosphatase activity (polynucleotide phosphohydrolase) is involved in the formation of the reovirus cap structure by releasing inorganic phosphate from the 5'-triphosphate end of the nascent mRNAs (1). The nature of the core protein involved in this process is currently unknown, but the lambda 1 protein, with its ability to release the terminal phosphate from free nucleotides, is certainly an attractive candidate to exert a similar activity on polynucleotides harboring a 5'-triphosphate end.


FOOTNOTES

*   This work was supported in part by a grant from the Medical Research Council of Canada (to G. L.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Recipient of a studentship from the Fonds pour la Formation de Chercheurs et l'Aide à la Recherche.
§   Recipient of a Chercheur-Boursier award from the Fonds de la Recherche en Santé du Québec. To whom correspondence should be addressed: Dépt. de Microbiologie et Immunologie, Université de Montréal, P. O. Box 6128, Station Centre-ville, Montréal, Québec H3C 3J7, Canada. Tel.: 514-343-2422; Fax: 514-343-5701; E-mail: lemayg{at}ere.umontreal.ca.
1   The abbreviations used are: dsRNA, double-stranded RNA; dsDNA, double-stranded DNA; NTP, nucleoside 5'-triphosphate; dNTP, deoxynucleoside 5'-triphosphate; NTPase, nucleoside triphosphate phosphohydrolase; dNTPase, deoxynucleoside triphosphate phosphohydrolase.
2   M. Bisaillon and G. Lemay, submitted for publication.
3   M. Bisaillon and G. Lemay, unpublished results.

ACKNOWLEDGEMENTS

We thank Carole Danis for expert technical assistance and Dr. Pierre Belhumeur for suggesting the use of the yeast expression system. We also thank Dr. Michael R. Roner for the generous gift of the anti-lambda 1 antibody.


REFERENCES

  1. Nibert, M. L., Schiff, L. A., and Fields, B. N. (1996) Fundamental Virology, 3rd Ed., pp. 691-730, Lippincott-Raven Publishers, Philadelphia
  2. Drayna, D., and Fields, B. N. (1982) J. Virol. 41, 110-118 [Medline] [Order article via Infotrieve]
  3. Matson, S. W., and Kaiser-Rogers, K. A. (1990) Annu. Rev. Biochem. 59, 289-329 [CrossRef][Medline] [Order article via Infotrieve]
  4. Thömmes, P., and Hübscher, U. (1990) FEBS Lett. 268, 325-328 [CrossRef]
  5. Gorbalenya, A. E., Koonin, E. V., Donchenko, A. P., and Blinov, V. M. (1989) Nucleic Acids Res. 17, 4713-4730 [Abstract]
  6. Yang, L., Mohr, I., Fouts, E., Lim, D. A., Nohaile, M., and Botchan, M. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 5086-5090 [Abstract]
  7. Fanning, E., and Knippers, R. (1992) Annu. Rev. Biochem. 61, 55-85 [CrossRef][Medline] [Order article via Infotrieve]
  8. Jindal, H. K., Young, C. B., Wilson, G. M., Tam, P., and Astell, C. R. (1994) J. Biol. Chem. 269, 3283-3289 [Abstract/Free Full Text]
  9. Lohman, T. M. (1992) Mol. Microbiol. 6, 5-14 [Medline] [Order article via Infotrieve]
  10. Lohman, T. M. (1993) J. Biol. Chem. 268, 2269-2272 [Abstract/Free Full Text]
  11. Matson, S. W. (1991) Prog. Nucleic Acid Res. Mol. Biol. 40, 289-326 [Medline] [Order article via Infotrieve]
  12. Li, J. P., and Baltimore, D. (1988) J. Virol. 62, 4016-4021 [Medline] [Order article via Infotrieve]
  13. Gorbalenya, A. E., and Koonin, E. V. (1989) Curr. Opin. Struct. Biol. 3, 419-429
  14. Hodgman, T. C. (1988) Nature 333, 22-23 [Medline] [Order article via Infotrieve]
  15. Gorbalenya, A. E., Koonin, E. V., Donchenko, A. P., and Blinov, V. M. (1988) Nature 333, 22 [Medline] [Order article via Infotrieve]
  16. Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J. (1982) EMBO J. 1, 945-951 [Medline] [Order article via Infotrieve]
  17. Schmidt, S. R., and Linder, P. (1992) Mol. Microbiol. 6, 283-292 [Medline] [Order article via Infotrieve]
  18. Lemay, G., and Danis, C. (1994) J. Gen. Virol. 75, 3261-3266 [Abstract]
  19. Noble, S., and Nibert, M. L. (1997) J. Virol. 71, 2182-2191 [Abstract]
  20. Bartlett, J. A., and Joklik, W. K. (1988) Virology 167, 31-37 [Medline] [Order article via Infotrieve]
  21. Porath, J., Carlsson, J., Olsson, I., and Belfrage, G. (1975) Nature 258, 598-599 [Medline] [Order article via Infotrieve]
  22. Broyles, S. S., and Moss, B. (1987) Mol. Cell. Biol. 7, 7-14 [Medline] [Order article via Infotrieve]
  23. Im, D. S., and Muzyczka, N. (1990) Cell 61, 447-457 [Medline] [Order article via Infotrieve]
  24. Coombs, K. M. (1996) J. Virol. 70, 4237-4245 [Abstract]
  25. Coombs, K. M., Mak, S. C., and Petrycky, L. D. (1994) J. Virol. 68, 177-186 [Abstract]
  26. Kapuler, A. M., Mendelsohn, N., Klett, H., and Acs, G. (1970) Nature 225, 1209-1213 [Medline] [Order article via Infotrieve]
  27. Borsa, J., Grover, J., and Chapman, J. D. (1970) J. Virol. 6, 295-302 [Medline] [Order article via Infotrieve]
  28. Kapuler, A. M. (1970) Biochemistry 9, 4453-4457 [Medline] [Order article via Infotrieve]
  29. Starnes, M. C., and Joklik, W. K. (1993) Virology 193, 356-366 [CrossRef][Medline] [Order article via Infotrieve]
  30. Cashdollar, L. W. (1994) Res. Virol. 145, 277-285 [Medline] [Order article via Infotrieve]
  31. Clertant, P., Gaudray, P., May, E., and Cuzin, F. (1984) J. Biol. Chem. 259, 15196-15203 [Abstract/Free Full Text]
  32. Scheffner, M. R., Knippers, R., and Stahl, H. (1989) Cell 57, 955-963 [Medline] [Order article via Infotrieve]
  33. Bayliss, C. D., and Smith, G. L. (1996) J. Virol. 70, 794-800 [Abstract]
  34. Tai, C. L., Chi, W. K., Chen, D. S., and Hwang, L. H. (1996) J. Virol. 70, 8477-8484 [Abstract]
  35. Zhang, S., and Grosse, F. (1994) Biochemistry 33, 3906-3912 [Medline] [Order article via Infotrieve]
  36. Rikkonen, M., Peränen, J., and Kääriäinen, L. (1994) J. Virol. 68, 5804-5810 [Abstract]
  37. Suzich, J. A., Tamura, J. K., Palmer-Hill, F., Warrener, P., Grakoui, A., Rice, C. M., Feinstone, S. M., and Collett, M. S. (1993) J. Virol. 67, 6152-6158 [Abstract]
  38. Tamura, J. K., Warrener, P., and Collett, M. S. (1993) Virology 193, 1-10 [CrossRef][Medline] [Order article via Infotrieve]
  39. Warrener, P., Tamura, J. K., and Collett, M. S. (1993) J. Virol. 67, 989-996 [Abstract]
  40. Abramson, R. D., Dever, T. E., Lawson, T. G., Ray, B. K., Thach, R. E., and Merrick, W. C. (1987) J. Biol. Chem. 262, 3826-3832 [Abstract/Free Full Text]
  41. Hirling, H., Scheffner, M., Restle, T., and Stahl, H. (1989) Nature 339, 562-564 [CrossRef][Medline] [Order article via Infotrieve]
  42. Mao, Z., and Joklik, W. K. (1991) Virology 185, 377-386 [Medline] [Order article via Infotrieve]
  43. Faust, M., Hastings, K. E. M., and Millward, S. (1975) Nucleic Acids Res. 197, 1329-1343
  44. Furuichi, Y., Morgan, M., Muthukrishnan, S., and Shatkin, A. J. (1975) Proc. Natl. Acad. Sci. U. S. A. 72, 362-366 [Abstract]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.